Neogen Chemicals Crecimiento futuro
Future controles de criterios 5/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Neogen Chemicals de 58.5% y 28.3% por año respectivamente. Se prevé que el BPA crezca en un 55.7% al año. Se espera que la rentabilidad financiera sea de 12.1% en 3 años.
Información clave
58.5%
Tasa de crecimiento de los beneficios
55.67%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Chemicals | 20.2% |
| Tasa de crecimiento de los ingresos | 28.3% |
| Rentabilidad financiera futura | 12.15% |
| Cobertura de analistas | Good |
| Última actualización | 10 Apr 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Neogen Chemicals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 06
Earnings Miss: Neogen Chemicals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
Nov 16Recent updates
NEOGEN: Equity Fundraising Plans Will Pressure Elevated Future P E Multiple
Analysts have kept their price target for Neogen Chemicals steady at ₹1,335, citing only small refinements to their discount rate, revenue growth outlook and profit margin assumptions, along with a slightly lower future P/E multiple, rather than any major shift in the investment case. What's in the News On February 11, 2026, the board met to review unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025, and to evaluate various options for raising funds through equity and other securities in one or more tranches (company filing).NEOGEN: Future PE Reset Will Test Sustainability Of Recent Cost Improvements
Narrative Update Analysts have held the fair value estimate for Neogen Chemicals steady at ₹1,335.00 while updating assumptions on growth, margins and future P/E. This reflects recent research that cites stronger revenue and EBITDA performance, cost actions taking hold and higher external price targets in the range of roughly ₹540 to ₹1,000 equivalent.
NEOGEN: Raised Guidance And Cost Actions Will Support Higher Future Earnings Quality
Narrative Update Overview The revised analyst price target for Neogen Chemicals edges slightly lower to ₹1,756.25 from ₹1,769.57. This reflects updated assumptions around the discount rate, revenue growth, profit margin, and future P/E, while staying broadly aligned with recent Street research that has cited better revenue and EBITDA prints, higher guidance, and early benefits from cost actions.NEOGEN: Future P E Compression Will Challenge Optimism Around Cost Driven Margin Gains
Our updated fair value estimate for Neogen Chemicals shifts to ₹1,335 from ₹1,670 as analysts factor in slightly adjusted growth assumptions, a modestly lower discount rate, firmer profit margins and a reduced future P/E multiple, broadly in line with recent Street research that links higher targets in other names to improving revenue quality, cost actions and guidance. Analyst Commentary Street research around Neogen Chemicals points to a more measured setup, even as some peers in the sector see higher optimism baked into targets.NEOGEN: Raised Guidance And Cost Actions Will Support Richer Future Earnings Multiple
Analysts have trimmed their fair value estimate for Neogen Chemicals from ₹1,847 to about ₹1,770, as slightly softer revenue growth and margin inputs are being offset by a higher assumed future P/E multiple and recent Street target hikes following better than expected earnings and guidance. Analyst Commentary Recent Street research around Neogen Chemicals reflects a mix of optimism about execution and some caution on how durable the current momentum might be for earnings and valuation.NEOGEN: Raised Guidance And Cost Actions Will Support Further Upside
Narrative Update: Neogen Chemicals Analysts have lifted their price target on Neogen Chemicals to a range of about $10 to $12, up from $6.50 to $8. This change is attributed to the company’s recent revenue and EBITDA beat, raised guidance, and early benefits from portfolio execution and cost actions.NEOGEN: Raised Guidance And Upcoming Board Results Will Support Upside
Narrative Update The analyst price target for Neogen Chemicals has been adjusted from approximately ₹1,812 to ₹1,847 as analysts factor in recent research that points to steady fair value assumptions, a slightly higher discount rate, unchanged growth and margin inputs, and a modestly higher future P/E multiple in light of recent earnings commentary and guidance updates on Neogen. Analyst Commentary Recent Street research on Neogen Chemicals highlights a mix of optimism around execution and guidance, paired with some restraint on how far the valuation should stretch after the latest earnings release.NEOGEN: Steady Fair Value And Upcoming Results Will Support Upside
Analysts have kept their fair value estimate for Neogen Chemicals steady at ₹1,812.29 per share, with only marginal adjustments to the discount rate, revenue growth, profit margin and future P/E inputs that are too small to materially change the target at this time. What's in the News Board meeting scheduled for November 8, 2025, at 14:30 Indian Standard Time to review and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).NEOGEN: Market Perform Initiation Will Support Upside From Resilient Margins
Analysts have modestly revised their price target on Neogen Chemicals upward to $10, reflecting slightly higher long term growth expectations and largely stable margin and valuation assumptions. Analyst Commentary The latest initiation at a Market Perform rating with a $10 price target highlights a balanced view on Neogen Chemicals, with analysts seeing the current valuation as broadly aligned with its near to medium term growth prospects.NEOGEN: Market Perform Initiation Will Support Steady Future Return Potential
Analysts have nudged their price target for Neogen Chemicals slightly higher, reflecting a modest improvement in fair value to roughly ₹1,812 per share. This is supported by expectations of sustained high revenue growth and stable valuation multiples, despite only minor adjustments to discount rate and profit margin assumptions.Why We're Not Concerned Yet About Neogen Chemicals Limited's (NSE:NEOGEN) 26% Share Price Plunge
Dec 04NEOGEN: Broader Customer Base And Joint Venture Will Support Steady Future Returns
Analysts have maintained Neogen Chemicals' price target at $1,806.57, citing stable growth expectations and aligning their assessment with the recent initiation of a Market Perform rating by the Street. Analyst Commentary Bullish Takeaways Bullish analysts note Neogen Chemicals' consistent revenue growth, which supports the current valuation and underpins the stable price target.We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
Nov 16Analysts Are More Bearish On Neogen Chemicals Limited (NSE:NEOGEN) Than They Used To Be
Nov 14NEOGEN: Product Diversification Will Drive Long-Term Returns After New Joint Venture
Analysts have revised Neogen Chemicals' fair value target downward from ₹2,062.83 to ₹1,806.57. This adjustment is due to a slightly higher discount rate and moderated revenue growth expectations, as reflected in recent research updates.These 4 Measures Indicate That Neogen Chemicals (NSE:NEOGEN) Is Using Debt Extensively
Nov 11Expanding Lithium Battery Materials Will Secure Global Reach
Despite an upward revision in revenue growth forecasts, Neogen Chemicals’ consensus price target has been lowered to ₹2,062, primarily due to a substantial decline in its future P/E multiple. What's in the News Annual dividend decreased to INR 1 per share for FY 2024-25.
Merger With BuLi Chemicals Will Strengthen Market Position In Pharma And Agrochemicals
The merger and strategic product expansions aim to strengthen Neogen's market position and boost future export and domestic revenue growth.Neogen Chemicals Limited's (NSE:NEOGEN) P/S Is On The Mark
Feb 21Neogen Chemicals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 06Here's Why Neogen Chemicals (NSE:NEOGEN) Has A Meaningful Debt Burden
Dec 26The Returns On Capital At Neogen Chemicals (NSE:NEOGEN) Don't Inspire Confidence
Dec 10Why Neogen Chemicals' (NSE:NEOGEN) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 20Earnings Miss: Neogen Chemicals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
Nov 16Investors Appear Satisfied With Neogen Chemicals Limited's (NSE:NEOGEN) Prospects As Shares Rocket 36%
Sep 20We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
May 08Earnings Miss: Neogen Chemicals Limited Missed EPS By 24% And Analysts Are Revising Their Forecasts
May 05After Leaping 27% Neogen Chemicals Limited (NSE:NEOGEN) Shares Are Not Flying Under The Radar
Apr 26Are Neogen Chemicals Limited (NSE:NEOGEN) Investors Paying Above The Intrinsic Value?
Apr 12Neogen Chemicals (NSE:NEOGEN) Is Increasing Its Dividend To ₹2.75
Aug 11Neogen Chemicals Limited (NSE:NEOGEN) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 10Here's Why I Think Neogen Chemicals (NSE:NEOGEN) Is An Interesting Stock
Feb 09Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 3/31/2029 | 28,339 | 1,930 | 3,048 | N/A | 2 |
| 3/31/2028 | 22,353 | 1,266 | 1,834 | N/A | 8 |
| 3/31/2027 | 13,408 | 578 | -1,746 | N/A | 8 |
| 3/31/2026 | 8,471 | 295 | -7,176 | N/A | 8 |
| 12/31/2025 | 8,182 | 197 | N/A | N/A | N/A |
| 9/30/2025 | 7,996 | 261 | -4,707 | -1,228 | N/A |
| 6/30/2025 | 7,843 | 336 | N/A | N/A | N/A |
| 3/31/2025 | 7,776 | 348 | -1,217 | 1,960 | N/A |
| 12/31/2024 | 7,744 | 494 | N/A | N/A | N/A |
| 9/30/2024 | 7,374 | 404 | -2,715 | 915 | N/A |
| 6/30/2024 | 7,057 | 374 | N/A | N/A | N/A |
| 3/31/2024 | 6,907 | 357 | -3,319 | -291 | N/A |
| 12/31/2023 | 6,949 | 330 | N/A | N/A | N/A |
| 9/30/2023 | 7,168 | 467 | -1,457 | 149 | N/A |
| 6/30/2023 | 7,032 | 486 | N/A | N/A | N/A |
| 3/31/2023 | 6,862 | 500 | -1,341 | -303 | N/A |
| 12/31/2022 | 6,391 | 513 | N/A | N/A | N/A |
| 9/30/2022 | 5,855 | 471 | -2,320 | -836 | N/A |
| 6/30/2022 | 5,505 | 484 | N/A | N/A | N/A |
| 3/31/2022 | 4,873 | 446 | -1,687 | 14 | N/A |
| 12/31/2021 | 4,231 | 383 | N/A | N/A | N/A |
| 9/30/2021 | 3,757 | 364 | -2,093 | 311 | N/A |
| 6/30/2021 | 3,445 | 326 | N/A | N/A | N/A |
| 3/31/2021 | 3,364 | 313 | -515 | 836 | N/A |
| 12/31/2020 | 3,260 | 293 | N/A | N/A | N/A |
| 9/30/2020 | 3,231 | 290 | -246 | 272 | N/A |
| 6/30/2020 | 3,183 | 293 | N/A | N/A | N/A |
| 3/31/2020 | 3,061 | 287 | -634 | -345 | N/A |
| 12/31/2019 | 3,036 | 301 | N/A | N/A | N/A |
| 9/30/2019 | 2,846 | 262 | N/A | -154 | N/A |
| 6/30/2019 | 2,555 | 225 | N/A | N/A | N/A |
| 3/31/2019 | 2,391 | 209 | N/A | -37 | N/A |
| 3/31/2018 | 1,612 | 110 | N/A | 118 | N/A |
| 3/31/2017 | 1,101 | 77 | N/A | 2 | N/A |
| 3/31/2016 | 1,003 | 52 | N/A | 86 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (58.5% al año) de NEOGEN es superior a la tasa de ahorro (6.8%).
Beneficios vs. Mercado: Se prevé que los beneficios (58.5% al año) de NEOGEN crezcan más rápidamente que el mercado Indian (17.4% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de NEOGEN crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (28.3% al año) de NEOGEN crezcan más rápidamente que los del mercado Indian (11.3% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos (28.3% al año) de NEOGEN crezcan más rápidamente que un 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de NEOGEN sea baja dentro de 3 años (12.1%).
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/04/30 17:09 |
| Precio de las acciones al final del día | 2026/04/30 00:00 |
| Beneficios | 2025/12/31 |
| Ingresos anuales | 2025/03/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Neogen Chemicals Limited está cubierta por 21 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Asian Markets Securities Private Limited |
| Arun Prasath | Avendus Spark |